The WACC of Ultragenyx Pharmaceutical Inc (RARE) is 7.7%.
| Range | Selected | |
| Cost of equity | 8.80% - 11.90% | 10.35% |
| Tax rate | 0.50% - 0.70% | 0.60% |
| Cost of debt | 5.00% - 5.00% | 5.00% |
| WACC | 6.9% - 8.4% | 7.7% |
| Category | Low | High |
| Long-term bond rate | 3.9% | 4.4% |
| Equity market risk premium | 4.6% | 5.6% |
| Adjusted beta | 1.07 | 1.25 |
| Additional risk adjustments | 0.0% | 0.5% |
| Cost of equity | 8.80% | 11.90% |
| Tax rate | 0.50% | 0.70% |
| Debt/Equity ratio | 1 | 1 |
| Cost of debt | 5.00% | 5.00% |
| After-tax WACC | 6.9% | 8.4% |
| Selected WACC | 7.7% | |